Innovative access and pricing solutions
Our specialist market access team supports the world’s leading pharmaceutical, biotech and device manufacturers in market access, pricing and reimbursement. We provide our clients with the insights and recommendations they need to develop the value strategy for their technologies and optimise their revenues.
Find out about our new syndicated study:
Impact of COVID-19 on the market access landscape »
Our portfolio of services includes:
Director, Market Access
Brett is a Director and heads up our specialist market access team. Brett has managed and contributed to the development of pricing and reimbursement strategies for pharmaceuticals and medical devices in all stages of the product life-cycle across all major European markets, US, Japan, Canada as well as many emerging markets. Brett has particular experience in asset valuation and value communication as well as more complex pricing research: moderation of payer and KOL dyads, focus groups, advisory boards, mock formulary committees and P&R negotiation simulations.